Goal-directed therapy is not as simple as it seems.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 42119022.
- Also identified by DOI 10.1093/jbmr/zjag080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A case is discussed of a postmenopausal woman started on alendronate treatment based on a low T-score in the total hip. 3 yr later, her total hip score remains below -2.5, the target set by the ASBMR task force on goal-directed therapy.(1) The important question at this juncture is whether she should change to a different treatment that might result in better improvement in total hip BMD or if she should continue treatment with alendronate.